2018 Cholangiocarcinoma Foundation Annual Conference
The Cholangiocarcinoma Foundation's Annual Conference seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma by providing a forum to:
Increase knowledge central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma.
A New Perspective
Present a diversity of perspectives focused on clinical, basic, and translational research.
Stimulate multi-disciplinary, cross-institutional collaborations.
and inspire innovation.
Further, patients and caregivers having experienced the disease first-hand, learned about cholangiocarcinoma, shared their personal experiences, and contributed to future efforts to further cholangiocarcinoma research.
- Nurses specializing in oncology, intensive care, and palliative care
- Pharmaceutical Companies
- Government Regulators
- Patients, Caregivers and others invested in the field of cholangiocarcinoma
Funding for this conference was made possible (in part) by a Eugene Washington Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI) allowing 30 patients from around the world to take part in all facets of the conference including speaking, attending sessions, roundtable discussions, and networking events.
Funding for this conference was made possible (in part) by 1R13CA213778-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.